Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

ROBIS: strumento per valutare il rischio di bias nelle revisioni sistematiche.

Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS Group.

Recenti Prog Med. 2018 Sep;109(9):27e-29e. doi: 10.1701/2990.29933. Italian. No abstract available.

PMID:
30303186
2.

ROBIS: guida all'uso.

Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS Group.

Recenti Prog Med. 2018 Sep;109(9):1e-26e. doi: 10.1701/2990.29932. Italian. No abstract available.

PMID:
30303185
3.

[ROBIS: a new tool to assess risk of bias in systematic reviews was developed.]

Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS Group.

Recenti Prog Med. 2018 Sep;109(9):421-431. doi: 10.1701/2990.29928. Italian.

PMID:
30303184
4.

Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.

Bailey C, Scott LJ, Rogers CA, Reeves BC, Hamill B, Peto T, Chakravarthy U, Harding SP; writing committee for the IVAN Study Group.

Ophthalmology. 2018 Oct 6. pii: S0161-6420(17)33849-6. doi: 10.1016/j.ophtha.2018.07.013. [Epub ahead of print]

5.

Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study.

Doble B, Pufulete M, Harris JM, Johnson T, Lasserson D, Reeves BC, Wordsworth S.

Health Qual Life Outcomes. 2018 Sep 20;16(1):191. doi: 10.1186/s12955-018-1019-3.

6.

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.

Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U, Ennis S, Behar-Cohen F, Reeves BC, Sivaprasad S, Lotery A.

Eye (Lond). 2018 Sep 7. doi: 10.1038/s41433-018-0212-2. [Epub ahead of print]

PMID:
30194380
7.

Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial.

Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, Nolan JP, Reeves BC, Robinson M, Scott LJ, Smartt H, South A, Stokes EA, Taylor J, Thomas M, Voss S, Wordsworth S, Rogers CA.

JAMA. 2018 Aug 28;320(8):779-791. doi: 10.1001/jama.2018.11597.

PMID:
30167701
8.

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.

Pufulete M, Maishman R, Dabner L, Higgins JPT, Rogers CA, Dayer M, MacLeod J, Purdy S, Hollingworth W, Schou M, Anguita-Sanchez M, Karlström P, Shochat MK, McDonagh T, Nightingale AK, Reeves BC.

Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8.

9.

Near-patient coagulation testing to predict bleeding after cardiac surgery: a cohort study.

Mumford AD, Harris J, Plummer Z, Lee K, Verheyden V, Reeves BC, Rogers CA, Angelini GD, Murphy GJ.

Res Pract Thromb Haemost. 2017 Jul 25;1(2):242-251. doi: 10.1002/rth2.12024. eCollection 2017 Oct.

10.
11.

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial.

Baos S, Underwood W, Culliford L, Reeves BC, Rogers CA, Bowles R, Johnson T, Baumbach A, Mumford A.

Trials. 2017 Nov 9;18(1):529. doi: 10.1186/s13063-017-2277-9.

12.

A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.

Hollingworth W, Jones T, Reeves BC, Peto T.

BMJ Open. 2017 Oct 22;7(10):e018289. doi: 10.1136/bmjopen-2017-018289.

13.

Development of a single, practical measure of surgical site infection (SSI) for patient report or observer completion.

Macefield RC, Reeves BC, Milne TK, Nicholson A, Blencowe NS, Calvert M, Avery KN, Messenger DE, Bamford R, Pinkney TD, Blazeby JM.

J Infect Prev. 2017 Jul;18(4):170-179. doi: 10.1177/1757177416689724. Epub 2017 Feb 1.

14.

Diagnostic and therapeutic medical devices for safer blood management in cardiac surgery: systematic reviews, observational studies and randomised controlled trials.

Murphy GJ, Mumford AD, Rogers CA, Wordsworth S, Stokes EA, Verheyden V, Kumar T, Harris J, Clayton G, Ellis L, Plummer Z, Dott W, Serraino F, Wozniak M, Morris T, Nath M, Sterne JA, Angelini GD, Reeves BC.

Southampton (UK): NIHR Journals Library; 2017 Sep.

15.

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA.

BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008. No abstract available.

16.

A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial.

Bluebelle Study Group, Reeves BC, Andronis L, Blazeby JM, Blencowe NS, Calvert M, Coast J, Draycott T, Donovan JL, Gooberman-Hill R, Longman RJ, Magill L, Mathers JM, Pinkney TD, Rogers CA, Rooshenas L, Torrance A, Welton NJ, Woodward M, Ashton K, Bera KD, Clayton GL, Culliford LA, Dumville JC, Elliott D, Ellis L, Gould-Brown H, Macefield RC, McMullan C, Pope C, Siassakos D, Strong S, Talbot H.

Trials. 2017 Aug 29;18(1):401. doi: 10.1186/s13063-017-2102-5.

17.

Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.

Pufulete M, Maishman R, Dabner L, Mohiuddin S, Hollingworth W, Rogers CA, Higgins J, Dayer M, Macleod J, Purdy S, McDonagh T, Nightingale A, Williams R, Reeves BC.

Health Technol Assess. 2017 Aug;21(40):1-150. doi: 10.3310/hta21400.

18.

Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

Pufulete M, Brierley RC, Bucciarelli-Ducci C, Greenwood JP, Dorman S, Anderson RA, Harris J, McAlindon E, Rogers CA, Reeves BC.

BMJ Open. 2017 Jun 22;7(6):e014627. doi: 10.1136/bmjopen-2016-014627. Review.

19.

Comparative costs and activity from a sample of UK clinical trials units.

Hind D, Reeves BC, Bathers S, Bray C, Corkhill A, Hayward C, Harper L, Napp V, Norrie J, Speed C, Tremain L, Keat N, Bradburn M.

Trials. 2017 May 2;18(1):203. doi: 10.1186/s13063-017-1934-3.

20.

Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR).

Lewin S, Hendry M, Chandler J, Oxman AD, Michie S, Shepperd S, Reeves BC, Tugwell P, Hannes K, Rehfuess EA, Welch V, Mckenzie JE, Burford B, Petkovic J, Anderson LM, Harris J, Noyes J.

BMC Med Res Methodol. 2017 Apr 26;17(1):76. doi: 10.1186/s12874-017-0349-x.

21.

Quasi-experimental study designs series-paper 5: a checklist for classifying studies evaluating the effects on health interventions-a taxonomy without labels.

Reeves BC, Wells GA, Waddington H.

J Clin Epidemiol. 2017 Sep;89:30-42. doi: 10.1016/j.jclinepi.2017.02.016. Epub 2017 Mar 27.

22.

Delivering successful randomized controlled trials in surgery: Methods to optimize collaboration and study design.

Blencowe NS, Cook JA, Pinkney T, Rogers C, Reeves BC, Blazeby JM.

Clin Trials. 2017 Apr;14(2):211-218. doi: 10.1177/1740774516687272. Epub 2017 Jan 31.

PMID:
28135839
23.

Dressings for the prevention of surgical site infection.

Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T, Macefield R, Blencowe N, Milne TK, Reeves BC, Blazeby J.

Cochrane Database Syst Rev. 2016 Dec 20;12:CD003091. doi: 10.1002/14651858.CD003091.pub4. Review.

PMID:
27996083
24.

A Core Outcome Set for the Benefits and Adverse Events of Bariatric and Metabolic Surgery: The BARIACT Project.

Coulman KD, Hopkins J, Brookes ST, Chalmers K, Main B, Owen-Smith A, Andrews RC, Byrne J, Donovan JL, Mazza G, Reeves BC, Rogers CA, Thompson JL, Welbourn R, Wordsworth S, Blazeby JM; BARIACT working group.

PLoS Med. 2016 Nov 29;13(11):e1002187. doi: 10.1371/journal.pmed.1002187. eCollection 2016 Nov.

25.

StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

Neffendorf JE, Desai R, Wang Y, Kelly J, Murphy C, Reeves BC, Chakravarthy U, Wordsworth S, Lewis C, Peacock J, Uddin S, O'Sullivan JM, Jackson TL.

Trials. 2016 Nov 24;17(1):560.

26.

The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial.

Reeves BC, Scott LJ, Taylor J, Hogg R, Rogers CA, Wordsworth S, Townsend D, Muldrew A, Peto T, Violato M, Dakin H, Cappel-Porter H, Mills N, O'Reilly D, Harding SP, Chakravarthy U.

Health Technol Assess. 2016 Oct;20(80):1-120.

27.

Design and implementation of the AIRWAYS-2 trial: A multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrest.

Taylor J, Black S, J Brett S, Kirby K, Nolan JP, Reeves BC, Robinson M, Rogers CA, Scott LJ, South A, Stokes EA, Thomas M, Voss S, Wordsworth S, Benger JR.

Resuscitation. 2016 Dec;109:25-32. doi: 10.1016/j.resuscitation.2016.09.016. Epub 2016 Sep 30.

28.

The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.

Hollingworth W, Biswas M, Maishman RL, Dayer MJ, McDonagh T, Purdy S, Reeves BC, Rogers CA, Williams R, Pufulete M.

Int J Cardiol. 2016 Dec 1;224:132-138. doi: 10.1016/j.ijcard.2016.09.021. Epub 2016 Sep 15.

PMID:
27648982
29.

A Comparison of Health Professionals' and Patients' Views of the Importance of Outcomes of Bariatric Surgery.

Coulman KD, Howes N, Hopkins J, Whale K, Chalmers K, Brookes S, Nicholson A, Savovic J, Ferguson Y, Owen-Smith A, Blazeby J; By-Band-Sleeve Trial Management Group, Blazeby J, Welbourn R, Byrne J, Donovan J, Reeves BC, Wordsworth S, Andrews R, Thompson JL, Mazza G, Rogers CA.

Obes Surg. 2016 Nov;26(11):2738-2746.

30.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP.

BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919. No abstract available.

31.

A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).

Reeves BC, Pike K, Rogers CA, Brierley RC, Stokes EA, Wordsworth S, Nash RL, Miles A, Mumford AD, Cohen A, Angelini GD, Murphy GJ.

Health Technol Assess. 2016 Aug;20(60):1-260. doi: 10.3310/hta20600.

32.

Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.

Reeves BC, Scott LJ, Taylor J, Harding SP, Peto T, Muldrew A, Hogg RE, Wordsworth S, Mills N, O'Reilly D, Rogers CA, Chakravarthy U.

BMJ Open. 2016 Jul 8;6(7):e010685. doi: 10.1136/bmjopen-2015-010685.

33.

Adherence to transfusion strategies in a randomized controlled trial: experiences from the TITRe2 trial.

Pike K, Maishman RL, Brierley RCM, Rogers CA, Murphy GJ, Reeves BC.

Br J Haematol. 2017 Oct;179(2):346-349. doi: 10.1111/bjh.14220. Epub 2016 Jul 5. No abstract available.

34.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC.

Kidney Int. 2016 Aug;90(2):411-421. doi: 10.1016/j.kint.2016.03.033. Epub 2016 Jun 1. Review. Erratum in: Kidney Int. 2017 Mar;91(3):758.

35.

Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery.

Emanueli C, Shearn AI, Laftah A, Fiorentino F, Reeves BC, Beltrami C, Mumford A, Clayton A, Gurney M, Shantikumar S, Angelini GD.

PLoS One. 2016 Apr 29;11(4):e0154274. doi: 10.1371/journal.pone.0154274. eCollection 2016.

36.

Isolated Human Pulmonary Artery Structure and Function Pre- and Post-Cardiopulmonary Bypass Surgery.

Dora KA, Stanley CP, Al Jaaly E, Fiorentino F, Ascione R, Reeves BC, Angelini GD.

J Am Heart Assoc. 2016 Feb 23;5(2). pii: e002822. doi: 10.1161/JAHA.115.002822.

37.

Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis.

Patel NN, Avlonitis VS, Jones HE, Reeves BC, Sterne JA, Murphy GJ.

Lancet Haematol. 2015 Dec;2(12):e543-53. doi: 10.1016/S2352-3026(15)00198-2. Epub 2015 Nov 17. Review.

PMID:
26686409
38.

The Effect of Patient-Specific Cerebral Oxygenation Monitoring on Postoperative Cognitive Function: A Multicenter Randomized Controlled Trial.

Ellis L, Murphy GJ, Culliford L, Dreyer L, Clayton G, Downes R, Nicholson E, Stoica S, Reeves BC, Rogers CA.

JMIR Res Protoc. 2015 Dec 18;4(4):e137. doi: 10.2196/resprot.4562.

39.

A Study of Platelet Inhibition, Using a 'Point of Care' Platelet Function Test, following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction [PINPOINT-PPCI].

Johnson TW, Mumford AD, Scott LJ, Mundell S, Butler M, Strange JW, Rogers CA, Reeves BC, Baumbach A.

PLoS One. 2015 Dec 16;10(12):e0144984. doi: 10.1371/journal.pone.0144984. eCollection 2015.

40.

Mini Bypass and Proinflammatory Leukocyte Activation: A Randomized Controlled Trial.

Nguyen BA, Fiorentino F, Reeves BC, Baig K, Athanasiou T, Anderson JR, Haskard DO, Angelini GD, Evans PC.

Ann Thorac Surg. 2016 Apr;101(4):1454-63. doi: 10.1016/j.athoracsur.2015.09.029. Epub 2015 Nov 18.

PMID:
26602006
41.

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN).

Chakravarthy U, Harding SP, Rogers CA, Downes S, Lotery AJ, Dakin HA, Culliford L, Scott LJ, Nash RL, Taylor J, Muldrew A, Sahni J, Wordsworth S, Raftery J, Peto T, Reeves BC.

Health Technol Assess. 2015 Oct;19(78):1-298. doi: 10.3310/hta19780.

42.

Propofol cardioplegia: A single-center, placebo-controlled, randomized controlled trial.

Rogers CA, Bryan AJ, Nash R, Suleiman MS, Baos S, Plummer Z, Hillier J, Davies I, Downes R, Nicholson E, Reeves BC, Angelini GD.

J Thorac Cardiovasc Surg. 2015 Dec;150(6):1610-9.e13. doi: 10.1016/j.jtcvs.2015.06.044. Epub 2015 Jun 30.

43.

Liberal or Restrictive Transfusion after Cardiac Surgery.

Reeves BC, Rogers CA, Murphy GJ.

N Engl J Med. 2015 Jul 9;373(2):193. doi: 10.1056/NEJMc1505810. No abstract available.

44.

ROBIS: A new tool to assess risk of bias in systematic reviews was developed.

Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, Davies P, Kleijnen J, Churchill R; ROBIS group.

J Clin Epidemiol. 2016 Jan;69:225-34. doi: 10.1016/j.jclinepi.2015.06.005. Epub 2015 Jun 16.

45.
46.

Transfusion Indication Threshold Reduction (TITRe2) randomized controlled trial in cardiac surgery: statistical analysis plan.

Pike K, Nash RL, Murphy GJ, Reeves BC, Rogers CA.

Trials. 2015 Feb 22;16:54. doi: 10.1186/s13063-015-0564-x.

47.

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial.

Foss AJ, Childs M, Reeves BC, Empeslidis T, Tesha P, Dhar-Munshi S, Mughal S, Culliford L, Rogers CA, Tan W, Montgomery A.

Trials. 2015 Mar 10;16:85. doi: 10.1186/s13063-015-0608-2.

48.

Liberal or restrictive transfusion after cardiac surgery.

Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC; TITRe2 Investigators.

N Engl J Med. 2015 Mar 12;372(11):997-1008. doi: 10.1056/NEJMoa1403612. Erratum in: N Engl J Med. 2015 Jun 4;372(23):2274.

49.

Systemic safety of anti-VEGF drugs: a commentary.

Scott LJ, Chakravarthy U, Reeves BC, Rogers CA.

Expert Opin Drug Saf. 2015 Mar;14(3):379-88. doi: 10.1517/14740338.2015.991712. Epub 2014 Dec 9. Review.

PMID:
25489638
50.

Reporting of harms in systematic reviews and their primary studies.

Reeves BC.

BMJ. 2014 Nov 21;349:g6819. doi: 10.1136/bmj.g6819. No abstract available.

PMID:
25416500

Supplemental Content

Loading ...
Support Center